122 related articles for article (PubMed ID: 15125383)
1. [Fulminant myocarditis treated with percutaneous cardiopulmonary support and long-term complications: three case reports].
Kusaba T; Nakahara Y; Matsumuro A; Nakamura T; Sawada S
J Cardiol; 2004 Apr; 43(4):185-91. PubMed ID: 15125383
[TBL] [Abstract][Full Text] [Related]
2. Fulminant myocarditis treated with percutaneous cardiopulmonary support system (PCPS).
Oshima K; Kunimoto F; Hinohara H; Hayashi Y; Hirato J; Tajima Y; Kuwano H
Ann Thorac Cardiovasc Surg; 2008 Apr; 14(2):75-80. PubMed ID: 18414343
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of percutaneous cardiopulmonary support in severe heart failure: early results and analysis of complications.
Sakamoto S; Matsubara J; Matsubara T; Nagayoshi Y; Shono S; Nishizawa H; Kanno M; Takeuchi K; Nonaka T; Kyosawa J
Ann Thorac Cardiovasc Surg; 2003 Apr; 9(2):105-10. PubMed ID: 12732087
[TBL] [Abstract][Full Text] [Related]
4. Improved survival after cardiac arrest using emergent autopriming percutaneous cardiopulmonary support.
Sung K; Lee YT; Park PW; Park KH; Jun TG; Yang JH; Ha YK
Ann Thorac Surg; 2006 Aug; 82(2):651-6. PubMed ID: 16863780
[TBL] [Abstract][Full Text] [Related]
5. [Long-term application of percutaneous cardiopulmonary support system without systemic heparinization].
Miura M; Fukuju T
Kyobu Geka; 2004 Feb; 57(2):115-8. PubMed ID: 14978904
[TBL] [Abstract][Full Text] [Related]
6. [Application of heparin-coated percutaneous cardiopulmonary support system to elective cardiac and aortic operations].
Watanabe SI; Hayashi K; Yamanishi H; Tomioka H; Minami M; Shindo N; Miyamoto K
Kyobu Geka; 1997 May; 50(5):362-7. PubMed ID: 9136530
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience of percutaneous cardiopulmonary support.
Sasako Y; Nakatani T; Nonogi H; Miyazaki S; Kito Y; Takano H; Kawashima Y
Artif Organs; 1996 Jun; 20(6):733-6. PubMed ID: 8817989
[TBL] [Abstract][Full Text] [Related]
8. [A case of fulminant myocarditis successfully treated by percutaneous cardiopulmonary support after 50 minuite-cardiopulmonary resuscitation].
Asano M; Soen M; Doi Y; Kishi K; Okumura K; Mori Y; Nemoto S; Hayashi M; Umegaki O; Minami T
Masui; 2013 Feb; 62(2):178-82. PubMed ID: 23479919
[TBL] [Abstract][Full Text] [Related]
9. Multiple organ failure caused by end-stage liver disease successfully treated with living donor liver transplantation using perioperative percutaneous cardiopulmonary support: a case report.
Hayashi H; Shimizu K; Tani T; Takamura H; Takeshita M; Funaki K; Kitagawa H; Kayahara M; Ota T; Miwa K
Transplant Proc; 2005 Mar; 37(2):1101-3. PubMed ID: 15848635
[TBL] [Abstract][Full Text] [Related]
10. [Relatively long time use of percutaneous cardiopulmonary support after unsuccessful weaning from intra-operative extracorporeal circulation--clinical considerations from an experience of 5 patients].
Yamanishi H; Watanabe S; Hayashi K
Nihon Kyobu Geka Gakkai Zasshi; 1995 Oct; 43(10):1783-7. PubMed ID: 7594840
[TBL] [Abstract][Full Text] [Related]
11. [Fulminant myocarditis successfully treated with a left ventricular assist device: a case report].
Ueno K; Konishi T; Fukata M; Furukawa H; Usui T; Kato K
J Cardiol; 2003 May; 41(5):249-54. PubMed ID: 12795115
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of emergent percutaneous cardiopulmonary support in cardiac or respiratory failure: fight or flight?
Shinn SH; Lee YT; Sung K; Min S; Kim WS; Park PW; Ha YK
Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):269-73. PubMed ID: 19429637
[TBL] [Abstract][Full Text] [Related]
13. Preclinical assessment of a transaortic venting catheter for percutaneous cardiopulmonary support.
Kitamura M; Hanzawa K; Takekubo M; Aoki K; Hayashi J
Artif Organs; 2004 Mar; 28(3):298-302. PubMed ID: 15046629
[TBL] [Abstract][Full Text] [Related]
14. Rescue of a child with fulminant myocarditis using percutaneous cardiopulmonary support.
Inoue Y; Kaneko H; Yoshizawa Y; Morikawa A
Pediatr Cardiol; 2000; 21(2):158-60. PubMed ID: 10754088
[TBL] [Abstract][Full Text] [Related]
15. Fulminant myocarditis survivor after 56 hours of non-responsive cardiac arrest successfully returned to normal life by cardiac resynchronization therapy: a case report.
Sugamura K; Sugiyama S; Kawano H; Horio E; Ono S; Kojima S; Kaikita K; Sagishima K; Sakamoto T; Yoshimura M; Kinoshita Y; Ogawa H
J Cardiol; 2006 Dec; 48(6):345-52. PubMed ID: 17243629
[TBL] [Abstract][Full Text] [Related]
16. Successful management of fulminant myocarditis with left ventricular assist device: report of a severe case.
Unosawa S; Hata M; Sezai A; Niino T; Yoshitake I; Shimura K; Takamori T; Minami K
Ann Thorac Cardiovasc Surg; 2010 Aug; 16(1):48-51. PubMed ID: 20190711
[TBL] [Abstract][Full Text] [Related]
17. Nafamostat mesilate, as a treatment for heparin resistance, is not associated with perioperative ischemic stroke in patients undergoing cardiac surgery with cardiopulmonary bypass.
Kikura M; Tanaka K; Hiraiwa T; Tanaka K
J Cardiothorac Vasc Anesth; 2012 Apr; 26(2):239-44. PubMed ID: 22019206
[TBL] [Abstract][Full Text] [Related]
18. Off-pump exchange of short-term percutaneous ventricular assist device (VAD) to long-term implantable VAD in severe coagulopathy and multi-organ failure.
Busch J; Wojciechowski Z; Torre-Amione G; Loebe M
J Heart Lung Transplant; 2008 May; 27(5):572-4. PubMed ID: 18442727
[TBL] [Abstract][Full Text] [Related]
19. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors for the surgical repair of ventricular septal perforation; an 8-year multiinstitutional analysis].
Sugiki H; Murashita T; Kunihara T; Matsuzaki K; Shiiya N; Yasuda K
Kyobu Geka; 2005 Apr; 58(4):278-83. PubMed ID: 15828246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
